1. Home
  2. KBSX vs LUNG Comparison

KBSX vs LUNG Comparison

Compare KBSX & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FST Corp. Ordinary Shares

KBSX

FST Corp. Ordinary Shares

HOLD

Current Price

$0.94

Market Cap

50.6M

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$2.04

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBSX
LUNG
Founded
1976
1995
Country
Taiwan
United States
Employees
382
N/A
Industry
Recreational Games/Products/Toys
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.6M
57.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KBSX
LUNG
Price
$0.94
$2.04
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$5.38
AVG Volume (30 Days)
8.6K
671.3K
Earning Date
05-15-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.64
EPS
N/A
N/A
Revenue
N/A
$90,497,000.00
Revenue This Year
$18.65
$2.48
Revenue Next Year
$16.31
$18.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.01
52 Week Low
$0.81
$1.13
52 Week High
$1.77
$2.89

Technical Indicators

Market Signals
Indicator
KBSX
LUNG
Relative Strength Index (RSI) 48.26 71.07
Support Level $0.82 $1.27
Resistance Level $1.03 $2.14
Average True Range (ATR) 0.08 0.18
MACD 0.03 0.09
Stochastic Oscillator 34.92 84.62

Price Performance

Historical Comparison
KBSX
LUNG

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: